Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 3, 2005, Pages 652-658

  Poltinnikov, Igor M ^a   Fallon, Kevin ^a   Xiao, Yian ^a   Reiff, Jay E ^b   Curran Jr , Walter J ^a   Werner Wasik, Maria ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Esophagitis; Hypofractionation; Lung cancer; Non small cell; Reirradiation

Indexed keywords

DOSIMETRY; PATIENT TREATMENT; RADIOTHERAPY; TUMORS;

ACUTE ESOPHAGITIS (AE); LUNG TUMORS; NON-SMALL-CELL LUNG CANCER (NSCLC); REIRRADIATION;

PULMONARY DISEASES;

ADULT; AGED; ARTICLE; BODY BUILD; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DYSPNEA; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMAN; IMMOBILIZATION; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINUM TUMOR; PAIN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; SIMULATION; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

ACUTE DISEASE; ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; IMMOBILIZATION; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETREATMENT; STEREOTAXIC TECHNIQUES;

EID: 20344379412     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.10.030     Document Type: Article

References (31)

1. T. LeChevalier, R. Arriagada, E. Quoix Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer First analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 1991 417 423
2. E.L. Gressen, M. Werner-Wasik, J. Cohn Reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer Am J Clin Oncol 23 2000 160 163
3. U. Hadinger, W. Thiele, J. Wulf Extracranial stereotactic radiotherapy Evaluation of PTV coverage and dose conformity Zeitschrift fur Medizinische Physik 12 2002 221 229
4. S.W. Lee, E.K. Choi, H.J. Park Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung Lung Cancer 40 2003 309 315
5. Y. Nagata, Y. Negoro, T. Aoki Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame Int J Radiat Oncol Biol Phys 52 2002 1041 1046
6. J.E. Reiff, M. Werner-Wasik, B.E. Garofola Stereotactic Body Frame immobilization and positioning device in an adaptive radiotherapy program of hypofractionated reirradiation regimens Stereotactic Body Radioablation Symposium 2002 Niagara Falls, Ontario, May 8-10
7. J. Wulf, U. Hadinger, U. Oppitz Stereotactic radiotherapy of extracranial targets CT-simulation and accuracy of treatment in the stereotactic body frame Radiother Oncol 57 2000 225 236
8. M. Mehta, R. Scrimger, R. Mackie A new approach to dose escalation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 49 2001 23 33
9. V. Donato, A. Zurlo, P. Bonfili Hypofractionated radiation therapy for inoperable advanced stage non-small cell lung cancer Tumori 85 1999 174 176
10. S. Appold, M. Baumann, F. Neidt Results of irradiation of inoperable stage III non-small-cell lung cancer with 25 Gy in five fractions Strahlenther Onkol 175 1999 267 270
11. B.J. Slotman, K.H. Njo, A. de Jonge Hypofractionated radiation therapy in unresectable stage III non-small cell lung cancer Cancer 72 1993 1885 1893
12. K.L. Wu, G.L. Jiang, H. Qian Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation A prospective phase I-II clinical trial Int J Radiat Oncol Biol Phys 57 2003 1345 1350
13. P.C.F. Cheung, L.T. Yeung, V. Basrur Accelerated hypofractionation for early stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 54 2002 1014 1023
14. S. Hirota, K. Tsujino, M. Endo Dosimetric predictors of radiation esophagitis in patients treated for non-small cell lung cancer with carboplatin/paclitaxel/radiotherapy Int J Radiat Oncol Biol Phys 51 2001 291 295
15. M. Werner-Wasik, E. Pequignot, D. Leeper Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus A multivariate analysis of patients with lung cancer treated with nonoperative therapy Int J Radiat Oncol Biol Phys 48 2000 689 696
16. P.D. Maguire, G.S. Sibley, S.M. Zhou Clinical and dosimetric predictors of radiation-induced esophageal toxicity Int J Radiat Oncol Biol Phys 45 1999 97 103
17. M.A. Jackson, D.L. Ball Palliative retreatment of locally recurrent lung cancer after radical radiotherapy Med J Aust 147 1987 391 394
18. J.F. Montebello, B.S. Aron, A.K. Manatunga The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation Am J Clin Oncol 16 1993 482 488
19. N. Green, R.W. Melbye Lung cancer Retreatment of local recurrence after definitive irradiation Cancer 49 1982 865 868
20. Y. Okamoto, M. Murakami, E. Yoden Reirradiation for locally recurrent lung cancer previously treated with radiation therapy Int J Radiat Oncol Biol Phys 52 2002 390 396
21. G. Fletcher Clinical dose-response curves of human malignant epithelial tumors Br J Radiol 46 1973 1 12
22. B. Emami Three-dimensional conformal radiation therapy in bronchogenic carcinoma Semin Radiat Oncol 6 1996 92 97
23. L.H. Gray, A.D. Conger, M. Ebert The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 1953 6528 6548
24. H. Choy, K. LaPorte, E. Knill-Selby Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer Semin Radiat Oncol 9 1999 90 96
25. M. Werner-Wasik, C. Scott, M.L. Graham Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy A multivariate analysis of 1076 RTOG patients Int J Radiat Oncol Biol Phys 44 1999 327 331
26. A.K. Singh, M.A. Lockett, J.D. Bradley Predictors of radiation-induced esophageal toxicity in patients with non-small cell lung cancer treated with three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 55 2003 337 341
27. B. Emami, J. Layman, A. Brown Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
28. A. Michalowski, S. Hornsey Assays of damage to the alimentary canal Br J Cancer 7 1986 1 6
29. D. Ball, J. Bishop, J. Smith A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer An interim toxicity analysis of the first 100 patients Int J Radiat Oncol Biol Phys 31 1995 267 272
30. J.G. Rosenman, J.S. Halle, M.A. Socinski High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small cell lung cancer Technical issues and results of a phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356
31. C.J. Langer, B. Movsas, R. Hudes Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma Report of Fox Chase Cancer Center study 94-001 Semin Radiat Oncol 24 1997 S12-89 S12-95